Pharmaceutical

FDA to review Regeneron’s sBLA for aflibercept injection 8mg

The FDA has accepted Regeneron Pharmaceuticals’ sBLA for Eylea HD (aflibercept) injection 8mg for priority review.

Apr 18, 2025 - 06:00
FDA to review Regeneron’s sBLA for aflibercept injection 8mg
The FDA has accepted Regeneron Pharmaceuticals’ sBLA for Eylea HD (aflibercept) injection 8mg for priority review.
Read the original article

Tags:

Previous Article

Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trial

Next Article

Bluebird bio reaffirms Carlyle deal as Ayrmid misses deadline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Abera and Orexo partner for vaccine powder formulations

Abera and Orexo partner for vaccine powder formulations

Dec 19, 2024

Gilead Sciences reports net income rise in Q2 2024

Gilead Sciences reports net income rise in Q2 2024

Aug 11, 2024

STAT+: ‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer

STAT+: ‘Are we better off with the information?’: Exper...

May 7, 2023